Medicinal Products

970. Deputy Alan Kelly asked the Minister for Health if all persons diagnosed with Duchenne muscular dystrophy will be entitled to access the drug Givinostat. [39474/25]

971. Deputy Alan Kelly asked the Minister for Health if an early access program or a compassionate use-managed access program will be established to allow quicker access to Givinostat for people with Duchenne muscular dystrophy. [39475/25]

979. Deputy Michael Cahill asked the Minister for Health to urgently expand the available sources for products (details supplied) to allow women in Kerry greater choice in where they can source the mastectomy products; and if she will make a statement on the matter. [39527/25]

175. Deputy Pádraig O'Sullivan asked the Minister for Health if she will consider increasing the dosage threshold for the treatment of type ii diabetes mellitus (details supplied) to 2 mg, bringing Ireland in line with neighbouring jurisdictions, as currently reimbursement support in Ireland is available for the licensed indication and dosage including and up to 0.25 mg/0.5 mg/1 mg strength provid…

200. Deputy David Cullinane asked the Minister for Health the reason a medication (details supplied) is administered in Letterkenny Hospital rather than in a community setting where its efficacy has been demonstrated through continued use for a patient, despite guidance from the manufacturer which states it is suitable for administration in the home; if she will consider a pilot scheme for communi…

218. Deputy Roderic O'Gorman asked the Minister for Health whether she has been made aware of the current shortage in Ireland of a number of pain relief medications (details supplied); if she can outline the role the Health Products Regulatory Authority can play in ensuring alternative supplies are made available to hospices and community pharmacies caring for these patients, whether this be by ex…

801. Deputy Ruth Coppinger asked the Minister for Health to consider expanding the free HRT scheme to include those treatments that are not covered under the drug payment scheme; and if she will make a statement on the matter. [37378/25]

810. Deputy Liam Quaide asked the Minister for Health when the HSE plans to complete a full health technology assessment in relation to EYLEA (aflibercept) given this was recommended by an NCPE Rapid Review assessment report in December 2012; and if she will make a statement on the matter. [37421/25]

817. Deputy Paul Lawless asked the Minister for Health if she is aware of the drug "ryeqo" to treat endometriosis; if she will be willing to consider adding it to the list of reimbursable items for medical card holders; and if she will make a statement on the matter. [37441/25]

834. Deputy Shane Moynihan asked the Minister for Health the steps that are being made to make Selumetinib available for children. [37501/25]

846. Deputy Paul Murphy asked the Minister for Health if her attention has been drawn to the case of a person (details supplied); and if she will instruct their Department to make oral immunotherapy as well as medicines such as omalizumab more widely available, to ensure situations like this do not happen again.; and if she will make a statement on the matter. [37593/25]

889. Deputy Martin Daly asked the Minister for Health if Veoza, aimed at women who are not suitable for HRT, will be covered under the free HRT scheme; and if she will make a statement on the matter. [37881/25]

346. Deputy Peadar Tóibín asked the Minister for Health if she allow for Mounjaro to be accessed on the medical card (details supplied). [36712/25]

223. Deputy Michael Healy-Rae asked the Minister for Health her views on the Medicines Management Programme plan to move all high protein oral supplements to List B; and if she will make a statement on the matter. [36243/25]

256. Deputy Cathal Crowe asked the Minister for Health if she will instruct the HSE to cease plans to move all high-protein oral nutritional supplements to list B (details supplied); and if she will make a statement on the matter. [36459/25]

679. Deputy Seán Canney asked the Minister for Health if the anti-sickness drug akynzeo can be made available on the GMS as it is the only effective anti-sickness medication for many cancer patients, including those with a brain tumour; if she is aware that the cost of buying this medical monthly is placing financial strain on families already dealing with illness; and if she will make a statement…

740. Deputy Peadar Tóibín asked the Minister for Health the protocols in place to review and adjust thyroid medication dosages for women following childbirth, particularly where the dosage was increased during pregnancy; in the absence of protocols, the measures that will be taken to ensure that postnatal thyroid treatment is appropriately monitored to avoid adverse effects such as depression and …

741. Deputy Peadar Tóibín asked the Minister for Health if she is aware of cases in which women have remained on elevated thyroid medication postpartum without review, resulting in serious mental health side effects including depression and suicidal thoughts; and if the HSE has conducted or will conduct any review or audit into such cases. [35519/25]

742. Deputy Peadar Tóibín asked the Minister for Health the clinical guidelines currently in place for general practitioners and endocrinologists regarding the monitoring and adjustment of thyroid hormone levels in postpartum women; and if updated guidance will be issued to ensure safer prescribing practices. [35520/25]

772. Deputy Claire Kerrane asked the Minister for Health if a full HTA application for the drug Veoza has been submitted, and when it is anticipated the HTA will be complete; and if she will make a statement on the matter. [35598/25]

785. Deputy Richard Boyd Barrett asked the Minister for Health the estimated full-year cost of introducing a fully funded universal contraception scheme; and if she will make a statement on the matter. [35677/25]

786. Deputy Richard Boyd Barrett asked the Minister for Health the estimated annual cost of free hormone replacement therapy for anyone who needs it; and if she will make a statement on the matter. [35678/25]

7. Deputy Shane Moynihan asked the Minister for Health if the Belgian model is being examined in the context of the programme for Government commitment to investigate early access schemes for rare disease treatments; and if she will make a statement on the matter. [34617/25]

66. Deputy William Aird asked the Minister for Health the current status of access to spinal muscular atrophy (SMA) treatments for adult patients; if she will commit to ensuring equitable public reimbursement of therapies for adults living with SMA; considering the urgent need expressed by patient groups; and if she will make a statement on the matter. [34829/25]

70. Deputy Conor D. McGuinness asked the Minister for Health if she will implement a plan to support individuals with Duchenne muscular dystrophy, including the development of specialist multidisciplinary teams, and ensuring enhanced and immediate access to givinostat and similar treatments. [34818/25]